Latest Fluicell News & Updates

See the latest news and media coverage for Fluicell. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Fluicell

Tissue engineering company for regenerative medicine and drug screening

fluicell.com
Headquarters
Mölndal, Sweden
Founded year
2012
Company type
Public company
Number of employees
2–20
Industry
Pharmaceuticals

Last updated

Latest news about Fluicell

In short: Fluicell achieved record revenues and transitioned to profitability in early 2026 while advancing its diabetes and cancer technologies.

Company announcements

Fluicell

The nomination committee proposes Karin Jennbacken as new board member

Karin Jennbacken is Executive Director at AstraZeneca with expertise in cardiovascular research and regenerative medicine. The proposal complements the board election to the annual general meeting 2026.

Unlock all announcements with a

Media coverage

Dagens industri

Fluicell turned to profit in the first quarter

Fluicell reports an operating result of 3.3 million kronor (-2.6) in the first quarter of 2026. Sales increased to 6.1 million kronor (0.2) with revenues of 8.4...

Dagens industri

Fluicell increases sales - reduces loss

The medical technology company Fluicell reports an operating result of -0.1 million kronor (-1.8) for the fourth quarter of 2025.

Unlock all articles with a

Never miss news about Fluicell

Track Fluicell and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Fluicell competitors & trending companies

Browse news for competitors to Fluicell and other trending companies.